![PDF) The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis PDF) The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis](https://i1.rgstatic.net/publication/367324987_The_Variations'_in_Genes_Encoding_TIM-3_and_Its_Ligand_Galectin-9_Influence_on_ccRCC_Risk_and_Prognosis/links/63cbe5bad7e5841e0be6fc79/largepreview.png)
PDF) The Variations' in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis
![Komisja Europejska zarejestrowała niwolumab w skojarzeniu z niską dawką ipilimumabu w leczeniu I linii zaawansowanego raka nerki - Onkologia – Termedia Komisja Europejska zarejestrowała niwolumab w skojarzeniu z niską dawką ipilimumabu w leczeniu I linii zaawansowanego raka nerki - Onkologia – Termedia](https://www.termedia.pl/f/pages/32845_d472ff18cf5304ddeeaee9ed7996a02d_blog.jpg)
Komisja Europejska zarejestrowała niwolumab w skojarzeniu z niską dawką ipilimumabu w leczeniu I linii zaawansowanego raka nerki - Onkologia – Termedia
![Skuteczność sawolitynibu w leczeniu pacjentów z rakiem brodawkowatym nerki: wyniki badania SAVOIR - Onkologia – Termedia Skuteczność sawolitynibu w leczeniu pacjentów z rakiem brodawkowatym nerki: wyniki badania SAVOIR - Onkologia – Termedia](https://www.termedia.pl/f/pages/39218_3b5b5c619aacbad0d6a658c8072e95fb_blog.jpg)
Skuteczność sawolitynibu w leczeniu pacjentów z rakiem brodawkowatym nerki: wyniki badania SAVOIR - Onkologia – Termedia
Synchroniczny przerzut zaawansowanego raka jasnokomórkowego nerki do jelita krętego. Opis przypadku klinicznego
![Biomedicines | Free Full-Text | Evaluation of Parameters Affecting the Occurrence of Systemic Inflammatory Response Syndrome in Patients Operated on Due to Kidney Tumors Biomedicines | Free Full-Text | Evaluation of Parameters Affecting the Occurrence of Systemic Inflammatory Response Syndrome in Patients Operated on Due to Kidney Tumors](https://www.mdpi.com/biomedicines/biomedicines-11-02195/article_deploy/html/images/biomedicines-11-02195-g004.png)
Biomedicines | Free Full-Text | Evaluation of Parameters Affecting the Occurrence of Systemic Inflammatory Response Syndrome in Patients Operated on Due to Kidney Tumors
![Ewa BARTNIK | Professor (Full) | Professor | University of Warsaw, Warsaw | UW | Institute of Genetics and Biotechnology | Research profile Ewa BARTNIK | Professor (Full) | Professor | University of Warsaw, Warsaw | UW | Institute of Genetics and Biotechnology | Research profile](https://www.researchgate.net/publication/372170428/figure/fig1/AS:11431281173177887@1688785212946/PEComa-tumor-radiological-imaging-and-resection-a-Intraoperative-picture-of-PEComa_Q320.jpg)
Ewa BARTNIK | Professor (Full) | Professor | University of Warsaw, Warsaw | UW | Institute of Genetics and Biotechnology | Research profile
![Biomedicines | Free Full-Text | Evaluation of Parameters Affecting the Occurrence of Systemic Inflammatory Response Syndrome in Patients Operated on Due to Kidney Tumors Biomedicines | Free Full-Text | Evaluation of Parameters Affecting the Occurrence of Systemic Inflammatory Response Syndrome in Patients Operated on Due to Kidney Tumors](https://pub.mdpi-res.com/biomedicines/biomedicines-11-02195/article_deploy/html/images/biomedicines-11-02195-g002.png?1692776044)
Biomedicines | Free Full-Text | Evaluation of Parameters Affecting the Occurrence of Systemic Inflammatory Response Syndrome in Patients Operated on Due to Kidney Tumors
Conjunctival metastasis of a renal cell carcinoma in a 59-year-old man – clinicopathological case report
![Kabozantynib w skojarzeniu z niwolumabem i ipilimumabem wydłuża PFS pacjentów z rakiem nerki - Onkologia – Termedia Kabozantynib w skojarzeniu z niwolumabem i ipilimumabem wydłuża PFS pacjentów z rakiem nerki - Onkologia – Termedia](https://www.termedia.pl/f/pages/51761_16e6d88f9ef8aab4cdcd57b9b4383cc3_blog.jpg)